After more than a decade of global consultation, polycystic ovary syndrome (PCOS) – a condition that affects one in eight women – has been renamed.
The hormonal disorder, estimated to impact 170 million women worldwide, will now be known as polyendocrine metabolic ovarian syndrome (PMOS).
The name change was published in the Lancetand announced at the European Congress of Endocrinology in Prague on Tuesday, after 14 years of collaboration between international societies and patient groups across six continents.
The renaming was spearheaded by the endocrinologist Prof Helena Teede, the director of Melbourne’s Monash Centre for Health Research & Implementation. For too long, experts including Teede say, the misleading nature of the term “polycystic” in PCOS contributed to delayed diagnosis and inadequate medical care.
after 14 years of collaboration between international societies and patient groups across six continents.
Just to change the name? It sounds like the meeting of the Ents in Lord of the Rings.
To better understand the disease, to the point that it’s so much better understood, the name itself was changed. This is big news, in a good way, and will lead to more people being diagnosed and treated faster.
polyendocrine metabolic ovarian syndrome (PMOS)
Doesn’t exactly roll off the tongue, and imho isn’t comprehensible by layman like “cyst”, but…
Teede says the new name “moves away from the incorrect focus on cysts … to recognising this is a much broader condition”. The effects of PMOS on the body “are virtually all endocrine – hormonal,” she says.
…is good if it focuses medicine to look at it the right way for treatment.
Now that they emphasize metabolism in describing the problem… will they tell people about the low cost way to fix their metabolism and hormonal disregulation? This article certainly didn’t
Meanwhile, people are still calling myalgic encephalomyelitis “chronic fatigue syndrome”.
